Skip to main content
. 2013 Nov 29;2013(11):CD010063. doi: 10.1002/14651858.CD010063.pub2

Kaats 1998.

Methods Parallel randomised controlled clinical trial
Participants Inclusion criteria: adults consulting their personal physician
Exclusion criteria: not stated
Diagnostic criteria: not stated
Interventions Number of study centres: 1
Treatment before study: not stated
Titration period: not stated
Outcomes Outcomes reported in abstract of publication: body weight, percentage body fat, fat mass and fat‐free mass
Study details Run‐in period: 90 days
Study terminated before regular end: no
Publication details Language of publication: English
Commercial funding: this study has been supported financially by Nutrition 21, Inc., San Diego, California
Publication status: peer review journal
Stated aim for study Quote: "To determining whether the body composition changes observed in the initial study could be replicated in this study"
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Comment: randomised, but method not stated
Allocation concealment (selection bias) Low risk Comment: independent local pharmacist
Blinding of participants and personnel (performance bias) 
 Objective outcomes Low risk Quote: "None of the investigators, research technicians dispensing the product, or participants knew which participant's number corresponded to the placebo or active product. An independent local pharmacist acted as trustee for the study and randomly assigned participant's numbers to bottles that had been prelabeled with either an “X” or “Y” to correspond with either active product or placebo"
Blinding of participants and personnel (performance bias) 
 Subjective outcomes Low risk Comment: no subjective outcomes
Blinding of outcome assessment (detection bias) 
 Objective outcomes Low risk Comment: not details provided
Blinding of outcome assessment (detection bias) 
 Subjective outcomes Low risk Comment: no subjective outcomes
Incomplete outcome data (attrition bias) 
 Objective outcomes Low risk Comment: no dropouts
Incomplete outcome data (attrition bias) 
 Subjective outcomes Low risk Comment: no subjective outcomes
Selective reporting (reporting bias) Low risk Comment: all of the outcomes listed in the methods section were reported as results
Other bias Unclear risk Comment: the trial had a commercial source of funding possibly creating a risk of bias